Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shortage Of Blood Products Means Record Sales For China Biologic Products

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China Biologic Products announced record financial results for the quarter ending Sept. 30, despite declining sales volumes

You may also be interested in...



Therapeutic Immunity? Plasma, Immunoglobulin Therapies Shield CSL From Global Financial Crisis

PERTH, Australia - Australian-headquartered CSL Limited has not been affected by the global financial crisis CEO Brian McNamee told analysts Feb. 18 during a half-year earnings call. Australia's financial year begins July 1 and ends June 30

Therapeutic Immunity? Plasma, Immunoglobulin Therapies Shield CSL From Global Financial Crisis

PERTH, Australia - Australian-headquartered CSL Limited has not been affected by the global financial crisis CEO Brian McNamee told analysts Feb. 18 during a half-year earnings call. Australia's financial year begins July 1 and ends June 30

China Biologic Starts Selling Human Immunoglobulin To Neighboring India, Scans Globe For New Markets

BEIJING - China Biologic Products has signed a unique deal to supply India with plasma-based biopharmaceuticals, and is scanning the global market for other potential importers, according to company executives

Related Content

UsernamePublicRestriction

Register

SC065956

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel